Literature DB >> 29412320

Effects of social protection on tuberculosis treatment outcomes in low or middle-income and in high-burden countries: systematic review and meta-analysis.

Kaio Vinicius Freitas de Andrade1, Joilda Silva Nery2, Ramon Andrade de Souza2, Susan Martins Pereira2.   

Abstract

Tuberculosis (TB) is a poverty infectious disease that affects millions of people worldwide. Evidences suggest that social protection strategies (SPS) can improve TB treatment outcomes. This study aimed to synthesize such evidences through systematic literature review and meta-analysis. We searched for studies conducted in low- or middle-income and in high TB-burden countries, published during 1995-2016. The review was performed by searching PubMed/MEDLINE, Scopus, Web of Science, ScienceDirect and LILACS. We included only studies that investigated the effects of SPS on TB treatment outcomes. We retained 25 studies for qualitative synthesis. Meta-analyses were performed with 9 randomized controlled trials, including a total of 1,687 participants. Pooled results showed that SPS was associated with TB treatment success (RR = 1.09; 95%CI: 1.03-1.14), cure of TB patients (RR = 1.11; 95%CI: 1.01-1.22) and with reduction in risk of TB treatment default (RR = 0.63; 95%CI: 0.45-0.89). We did not detect effects of SPS on the outcomes treatment failure and death. These findings revealed that SPS might improve TB treatment outcomes in lower-middle-income economies or countries with high burden of this disease. However, the overall quality of evidences regarding these effect estimates is low and further well-conducted randomized studies are needed.

Entities:  

Mesh:

Year:  2018        PMID: 29412320     DOI: 10.1590/0102-311X00153116

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  17 in total

1.  An assessment of current tuberculosis patient care and support policies in high-burden countries.

Authors:  A M Cocozza; N N Linh; R R Nathavitharana; U Ahmad; E Jaramillo; G E M Gargioni; G J Fox
Journal:  Int J Tuberc Lung Dis       Date:  2020-01-01       Impact factor: 2.373

2.  The impact of a cash transfer programme on tuberculosis treatment success rate: a quasi-experimental study in Brazil.

Authors:  Daniel J Carter; Rhian Daniel; Ana W Torrens; Mauro N Sanchez; Ethel Leonor N Maciel; Patricia Bartholomay; Draurio C Barreira; Davide Rasella; Mauricio L Barreto; Laura C Rodrigues; Delia Boccia
Journal:  BMJ Glob Health       Date:  2019-01-24

3.  Challenges in TB diagnosis and treatment: the Kavieng Provincial Hospital experience, Papua New Guinea.

Authors:  K Sodeng; A Botu; M Semmie; M Yoannes; H D Shewade; R Commons; S M Graham; P du Cros
Journal:  Public Health Action       Date:  2019-09-21

4.  Integrating tuberculosis and noncommunicable diseases care in low- and middle-income countries (LMICs): A systematic review.

Authors:  Chuan De Foo; Pami Shrestha; Leiting Wang; Qianmei Du; Alberto L García-Basteiro; Abu Saleh Abdullah; Helena Legido-Quigley
Journal:  PLoS Med       Date:  2022-01-18       Impact factor: 11.069

5.  Evaluation of a social protection policy on tuberculosis treatment outcomes: A prospective cohort study.

Authors:  Karen Klein; Maria Paula Bernachea; Sarah Irribarren; Luz Gibbons; Cristina Chirico; Fernando Rubinstein
Journal:  PLoS Med       Date:  2019-04-30       Impact factor: 11.069

6.  'I am on treatment since 5 months but I have not received any money': coverage, delays and implementation challenges of 'Direct Benefit Transfer' for tuberculosis patients - a mixed-methods study from South India.

Authors:  Abhay Subhashrao Nirgude; Ajay M V Kumar; Timire Collins; Poonam Ramesh Naik; Malik Parmar; Li Tao; Kibballi Madhukeshwar Akshaya; Pracheth Raghuveer; Santosh K Yatnatti; Navya Nagendra; Sharath B Nagaraja; Shaira Habeena; Badarudeen Mn; Ramkrishna Rao; Suresh Shastri
Journal:  Glob Health Action       Date:  2019       Impact factor: 2.640

7.  Tuberculosis in Brazil and cash transfer programs: A longitudinal database study of the effect of cash transfer on cure rates.

Authors:  Barbara Reis-Santos; Priya Shete; Adelmo Bertolde; Carolina M Sales; Mauro N Sanchez; Denise Arakaki-Sanchez; Kleydson B Andrade; M Gabriela M Gomes; Delia Boccia; Christian Lienhardt; Ethel L Maciel
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

8.  Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000-2016.

Authors:  Marcela Bhering; Raquel Duarte; Afrânio Kritski
Journal:  PLoS One       Date:  2019-11-20       Impact factor: 3.240

9.  Patient predictors of poor drug sensitive tuberculosis treatment outcomes in Kyiv Oblast, Ukraine.

Authors:  Omowunmi Aibana; Andrej Slavuckij; Mariya Bachmaha; Viatcheslav Krasiuk; Natasha Rybak; Timothy P Flanigan; Vasyl Petrenko; Megan B Murray
Journal:  F1000Res       Date:  2017-10-23

10.  Effect of a conditional cash transfer programme on leprosy treatment adherence and cure in patients from the nationwide 100 Million Brazilian Cohort: a quasi-experimental study.

Authors:  Julia M Pescarini; Elizabeth Williamson; Joilda S Nery; Anna Ramond; Maria Yury Ichihara; Rosemeire L Fiaccone; Maria Lucia F Penna; Liam Smeeth; Laura C Rodrigues; Gerson O Penna; Elizabeth B Brickley; Mauricio L Barreto
Journal:  Lancet Infect Dis       Date:  2020-02-14       Impact factor: 71.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.